您当前所在的位置:首页 > 产品中心 > 产品信息
Chenodeoxycholic acid_分子结构_CAS_474-25-9)
点击图片或这里关闭

Chenodeoxycholic acid

产品号 DB06777 公司名称 DrugBank
CAS号 474-25-9 公司网站 http://www.ualberta.ca/
分子式 C24H40O4 电 话 (780) 492-3111
分子量 392.572 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 4476

产品价格信息

请登录

产品别名

标题
Chenodeoxycholic acid
IUPAC标准名
(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid
IUPAC传统名
chendol
商标名
Chenix
Chenodal
Chenodiol
别名
Chenodesoxycholic acid
Chenodiol
Chenocholic acid

产品登记号

CAS号 474-25-9
PubChem CID 10133
PubChem SID 99443291

产品性质

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description Chenodeoxycholic acid (or Chenodiol) is an epimer of ursodeoxycholic acid (DB01586). Chenodeoxycholic acid is a bile acid naturally found in the body. It works by dissolving the cholesterol that makes gallstones and inhibiting production of cholesterol in the liver and absorption in the intestines, which helps to decrease the formation of gallstones. It can also reduce the amount of other bile acids that can be harmful to liver cells when levels are elevated.
Indication Chenodiol is indicated for patients with radiolucent stones in well-opacifying gallbladders, in whom selective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age. Chenodiol will not dissolve calcified (radiopaque) or radiolucent bile pigment stones.
Pharmacology It acts by reducing levels of cholesterol in the bile, helping gallstones that are made predominantly of cholesterol to dissolve. Chenodeoxycholic acid is ineffective with stones of a high calcium or bile acid content.
Toxicity Hepatotoxic.
Biotransformation Chenodiol is well absorbed from the small intestine and taken up by the liver where it is converted to its taurine and glycine conjugates and secreted in bile. At steady-state, an amount of chenodiol near the daily dose escapes to the colon and is converted by bacterial action to lithocholic acid. About 80% of the lithocholate is excreted in the feces; the remainder is absorbed and converted in the liver to its poorly absorbed sulfolithocholyl conjugates. During chenodiol therapy there is only a minor increase in biliary lithocholate, while fecal bile acids are increased three- to fourfold.
Absorption Chenodiol is well absorbed from the small intestine.
Elimination About 80% of its bacterial metabolite lithocholate is excreted in the feces.
External Links
Wikipedia
Drugs.com

参考文献